Abcuro

Abcuro is a biotechnology company developing antibody-based therapies targeting highly cytotoxic T cells involved in autoimmune diseases.

Latest funding

$66M Series B+ · August 18, 2026

Led by New Leaf Venture Partners · Source: fundraisingfox.com

Total raised: $463M across 4 sourced rounds

All 5 rounds ↓

Website: abcuro.com.

X: @AbcuroInc · 44 followers.

LinkedIn: linkedin.com.

Category: Health and bio.

Sectors: Biotechnology, Clinical Trials, Life Science, Oncology, Therapeutics.

Stage: Series B+.

Based in: Newton, United States.

Founded: 2016.

Total raised: $463M in 4 sourced rounds.

Last round: Aug 18, 2026 · 86 days ago.

Headcount: 51–100 employees.

On Recent Funding since: Nov 6, 2026.

Signals

X account@AbcuroInc · created Jan 7, 2021 (5 years old) · 44 followers

Website registeredOct 8, 2015 (11 years old)

TIMELINE · MONEY RAISED

Abcuro | 2925 days on the record

@AbcuroInc·Raised $463M in 4 sourced rounds

Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.

Funding rounds

August 18, 2026
Series B+ · $66M
NNew Leaf Venture Partners (lead), NNEA, PPontifax, RRA Capital Management, RRedmile Group, RRock Springs Capital, SSamsara Biocapital, SSanofi Ventures, SShangbay Capital, SSoleus Capital
Source: fundraisingfox.com
February 12, 2025
Series B+ · $200M
NNEA (lead), MMass General Brigham Ventures, NNew Leaf Venture Partners, PPontifax, RRA Capital Management, RRedmile Group, SSamsara Biocapital, SSanofi Ventures, SSoleus Capital
Source: citybiz.co
August 17, 2023
Series B+ · $155M
RRedmile Group (lead), EEurofarma, MMass General Brigham Ventures, NNew Leaf Venture Partners, PPontifax, RRA Capital Management, SSamsara Biocapital, SSanofi Ventures, SSoleus Capital, TTekla Capital Management
Source: pulse2.com
January 7, 2021
Series A · $42M
MMass General Brigham Ventures (lead), SSanofi Ventures (lead), HHongsen Investment Group, PPontifax, RRA Capital Management, SSamsara Biocapital
Source: boston.citybizlist.com
January 7, 2021
X account created
November 9, 2018
Series A · amount undisclosed
KKaitai Capital, PPartners Innovation Fund, SShangPharma Innovation
Source: abcuro.com
October 8, 2015
Website created

Founders and team

SG
Stefano Gullà Founder

@StefanoGulla · LinkedIn
SA
Steven A. Greenberg Founder
RO
Raquel Orozco Director
AM
Alex Martin Chief Executive Officer
CC
Courtney Cupples Chief Commercial Officer

Investors

Companies like Abcuro

ZZag BioSeries A
BBoulevard Bio$65M Seed · Aug 2026
KK2 Therapeutics$50M Seed · Aug 2026
FFlip TherapeuticsSeed · Sep 2026
PPushCART TherapeuticsSeed · Jul 2026
OOna Therapeutics$86.6M Series B+ · Oct 2026

Other companies backed by New Leaf Venture Partners

SStar Therapeutics$200M Series B+ · Oct 2026
WWindup MindsSeed · Sep 2026
CCleerlySeries B+ · Jan 2025
AAsimily

New Leaf Venture Partners portfolio →

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/abcuro (get a free API key).